Home
ColoHealth
Patient Information
Physician Information
CLIA Laboratory
Products
Colorectal Cancer
AxSpA
Patient Information
Physician Information
Celiac
H. pylori
Covid-Flu-RSV
COVID-19
Oncology Product Pipeline
ColoPlex Plus
Procare
About Us
Our Team
News
For Media
Case Study 2
CRO
Skills
Posted on
December 8, 2022
←
Case Study 1
Case Study 3: ColoPlex
→
Submit a Comment
Cancel reply
You must be
logged in
to post a comment.
Search
Search
Topics
Articles
Company Details
News and Events
Products & Pipeline
Research & Development
Uncategorized
Recent Posts
Press Release: ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening–Now Direct-to-Consumer
Hepion Pharmaceuticals, New Day Diagnostics execute binding letter of intent
Press Release: Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC
We’ve Been Busy, and the Press Has Noticed!
Knoxville lab launches blood test for colorectal cancer screening across US: ‘Life mission’